Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use

Franco Aversa; Alessandro Busca; Anna Candoni; Simone Cesaro; Corrado Girmenia; Mario Luppi; Anna Maria Nosari; Livio Pagano; Luigina Romani; Giuseppe Rossi; Adriano Venditti; Andrea Novelli

doi:10.1080/1120009X.2017.1306183

Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use

Franco Aversa
, Alessandro Busca
, Anna Candoni
, Simone Cesaro
, Corrado Girmenia
, Mario Luppi
, Anna Maria Nosari
, Livio Pagano
, Luigina Romani
, Giuseppe Rossi
, Adriano Venditti
, Andrea Novelli

University of Parma
Azienda Ospedaliera - Universitaria Città della Salute e della Scienza di Torino
Integrata
G.B. Rossi Hospital
University of Rome La Sapienza
University of Modena and Reggio Emilia
Asst Grande Ospedale Metropolitano Niguarda
University of Perugia
Spedali Civili Di Brescia
University of Rome Tor Vergata
University of Florence

Risultato della ricerca: Contributo in rivista › Articolo

13 Citazioni (Scopus)

Abstract

not done

Lingua originale	Inglese
pagine (da-a)	131-143
Numero di pagine	13
Rivista	Journal of Chemotherapy
DOI	https://doi.org/10.1080/1120009X.2017.1306183
Stato di pubblicazione	Pubblicato - 2017

Keywords

Antifungal activity
Antifungal prophylaxis
Immune-pharmacology
Invasive fungal infection
Liposomal amphotericin

Accesso al documento

10.1080/1120009X.2017.1306183

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{6deb0206a9a948788815efedd9c63c2c,

title = "Liposomal amphotericin B (AmBisome{\textregistered}) at beginning of its third decade of clinical use",

abstract = "not done",

keywords = "Antifungal activity, Antifungal prophylaxis, Immune-pharmacology, Invasive fungal infection, Liposomal amphotericin, Antifungal activity, Antifungal prophylaxis, Immune-pharmacology, Invasive fungal infection, Liposomal amphotericin",

author = "Franco Aversa and Alessandro Busca and Anna Candoni and Simone Cesaro and Corrado Girmenia and Mario Luppi and Nosari, \{Anna Maria\} and Livio Pagano and Luigina Romani and Giuseppe Rossi and Adriano Venditti and Andrea Novelli",

year = "2017",

doi = "10.1080/1120009X.2017.1306183",

language = "English",

pages = "131--143",

journal = "Journal of Chemotherapy",

issn = "1120-009X",

publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use

AU - Aversa, Franco

AU - Busca, Alessandro

AU - Candoni, Anna

AU - Cesaro, Simone

AU - Girmenia, Corrado

AU - Luppi, Mario

AU - Nosari, Anna Maria

AU - Pagano, Livio

AU - Romani, Luigina

AU - Rossi, Giuseppe

AU - Venditti, Adriano

AU - Novelli, Andrea

PY - 2017

Y1 - 2017

N2 - not done

AB - not done

KW - Antifungal activity

KW - Antifungal prophylaxis

KW - Immune-pharmacology

KW - Invasive fungal infection

KW - Liposomal amphotericin

KW - Antifungal activity

KW - Antifungal prophylaxis

KW - Immune-pharmacology

KW - Invasive fungal infection

KW - Liposomal amphotericin

UR - http://hdl.handle.net/10807/98130

U2 - 10.1080/1120009X.2017.1306183

DO - 10.1080/1120009X.2017.1306183

M3 - Article

SN - 1120-009X

SP - 131

EP - 143

JO - Journal of Chemotherapy

JF - Journal of Chemotherapy

ER -

Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo